The Traumatic Brain Injury Therapeutics Market is estimated to be valued at US$ 3.46 Billion In 2022 and is expected to exhibit a CAGR of 6.20% over the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights. Market Overview: Traumatic Brain Injury Therapeutics Market refers to the pharmaceutical products and therapies used in the treatment of traumatic...
0 Commentarios
0 Acciones
1045 Views
0 Vista previa
The traumatic brain injury therapeutics market comprises drugs and devices meant for the treatment of traumatic brain injuries. Traumatic brain injuries, also known as TBIs, occur due to a bump, blow or jolt to the head that disrupts normal brain functioning. Common causes of TBIs include falls, vehicle accidents, sports-related injuries and assaults. Therapeutics for TBIs include medications...
0 Commentarios
0 Acciones
517 Views
0 Vista previa